Browsing: Biotech
As gene therapy moves deeper into its second commercial decade, competitive advantage is shifting away from simple proof-of-concept toward control,…
When Novartis agreed to acquire Avidity Biosciences for approximately $12 billion, it did more than stand as one of the…
Insitro’s scientific thesis is deceptively simple: if human biology can be measured at sufficient scale and resolution, machine learning drug…
When Stephanie Culler co-founded Persephone Biosciences in 2017, she had a vision of decoding the microbiome to harness its potential…
In the rapidly evolving field of regenerative medicine, Juvena Therapeutics stands out not just for its technology, but for its…
Medicine is being increasingly driven by data. Advances in genomic sequencing, wearable devices for data collection, biomarker discoveries, and machine…
CellFE is a biotechnology company based in Almeda, California that specializes in microfluidic-based cellular engineering, aiming to revolutionize cell therapy…
Founded in 2019, PTM Therapeutics is a San Francisco-based, pre-clinical stage startup that strives to “develop therapeutics for the betterment…
Nabiha Saklayen, CEO of Cellino, was born in Saudi Arabia and raised partially in Germany and Sri Lanka. From a…
This past November 2023, Obatala Sciences ™ announced the commercial launch of its ObaCell® Obesity-on-a-Chip Service, a bioengineered model of…
Biomarkers are measurable signs that provide objective information about what is happening inside the body, such as: heart rate, blood…
Almost two-thirds of Americans living with Alzheimer’s disease are women. Women in their 60’s are more than twice as likely…
Yaso Therapeutics gel technology takes aim at sperm before they can reach an egg, creating a non-hormonal contraceptive that prevents…
Jurata Thin Film began as an idea to develop a novel way to deliver Ebola vaccines to low-income countries without…
Women have historically been denied the right to have a stake in the development of medical therapies targeting their health,…
Quantum computing has the potential to revolutionize how new drugs are developed. With the ability to take on challenges too…
ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers
Last week, President and Co-Founder Sumayah Jamhal presented her company, ENB Therapeutics, at the 2023 Immuno-Oncology 360 Degree Conference in…
A rare genetic respiratory disease affecting the tiny structures in the lungs that filter air is the target of promising…
A New Lymphoid Technology That Accelerates Immune Reconstitution in Hematopoietic Stem Cell Transplantation
Smart Immune is a clinical-stage biotechnology startup headquartered in France, developing a thymus-empowered T-cell therapy platform called ProTcell Platform. The…
Advanced neuroimaging techniques that can detect disease-linked proteins in the brain could be the key to quickly and accurately diagnosing…
One company’s approach to breaking barriers within the TME to overcome recalcitrant cancers. Earlier this month, a preview of patient-derived…
Prostate cancer is the second most common form of cancer affecting men in the United States – 1 in 8 men will…
Hope for Patients Diagnosed with Rare, Aggressive Desmoid Fibromatosis Last month, SpringWorks Therapeutics announced their promising data from the Phase…
June is recognized as World Infertility Awareness Month. As many as 48.5 million couples experience some form of infertility due…
Intra-Cellular Therapies FDA Approval for Bipolar Disorder Associated with Depression 
Intra-Cellular Therapies ended the year 2021 with a big achievement. On December 20, 2021, Dr. Sharon Mates, Chairman, and CEO…